Professor Malcolm Richardson PhD, FSB, FRCPath, FISSE

​Malcolm Richardson is the Director of the Regional Mycology Laboratory at the University Hospital of South Manchester and an honorary Professor of Medical Mycology at the University of Manchester. Prior to this position he was an Associate Professor in Medical Mycology at the University of Helsinki, Finland, with an affiliate appointment at the Helsinki University Central Hospital.

He is an elected Fellow of the Royal College of Pathologists and of the Institute of Biology. His clinical and laboratory investigations have focused on the pathogenicity, diagnosis and epidemiology of superficial and systemic fungal infections. More recently he has applied his diagnostic experience to investigating the role of moulds in “sick building syndrome”.

He has published over 350 original articles, book chapters and reviews and is the author or editor of fifteen mycological textbooks and handbooks, including Fungal Infection: Diagnosis and Management, 3rd Edition (2003), The Pocket Guide to Fungal infection, 2nd Edition (2006), Therapeutic Guidelines in Systemic Fungal Infection, 4th Edition (2007), and Fungal Infection and Critical Care Medicine (2008). Malcolm Richardson is a frequent speaker and session chair at major international conferences in the fields of clinical microbiology, infectious diseases, and medical mycology. His professional duties include being the Editor-in-Chief of Critical Reviews in Microbiology.

From 2003 to 2009 Malcolm Richardson was the General Secretary of the International Society of Human and Animal Mycology (ISHAM). Additional activities include acting as a consultant for various pharmaceutical and health care companies. Recently, Malcolm Richardson has joined the European Food Safety Authority’s Biohazard Working Group on the Qualified Presumption of Safety of Yeasts and Filamentous Fungi, and a WHO Working Group on Dampness and Mould.

Most recent contributions to the literature:

  • Richardson MD, Richardson R. How the host fights against Candida infections. Front Biosci (Schol Ed) 2009; 1: 246-57.
  • Rusanen P, Siikala E, Uittamo J, Richardson MD, Richardson R. A novel method for sampling the microbiota from the oral mucosa.Clin Oral Investig 2009; 13( 2): 243-6.Full text doi:10.1007/s00784-008-0225-5 further details
  • Richardson R, Richardson MD, Pfaller M, Perheentupa J, Saxén H. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.Diagn Microbiol Infect Dis 2008; 62( 2): 182-5.Full text doi:10.1016/j.diagmicrobio.2008.05.007 further details
  • Richardson R, Richardson MD, Pfaller M, Perheentupa J, Saxen H. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. Scand J Infect Dis 2008; 40( 11-12): 904-7.Full text doi:10.1080/00365540802275853 further details

Contacts:

Honorary Professor in Medical Mycology 
Regional Mycology Laboratory
Education and Research Centre
Wythenshawe Hospital
Southmoor Road
Manchester, M23 9LT, UK
E-mail [email protected]